Previous reports have demonstrated that LCN2 levels are increased in various cancers, such as breast, ovarian, colon, pancreatic, and thyroid cancer, and that LCN2 is associated with poor prognosis22. Here, LCN2 is linked to thyroid gland carcinoma.